IL113341A - Pharmaceutical compositions comprising aqueous intranasal antimigraine compounds together with chitosan and their preparation - Google Patents

Pharmaceutical compositions comprising aqueous intranasal antimigraine compounds together with chitosan and their preparation

Info

Publication number
IL113341A
IL113341A IL11334195A IL11334195A IL113341A IL 113341 A IL113341 A IL 113341A IL 11334195 A IL11334195 A IL 11334195A IL 11334195 A IL11334195 A IL 11334195A IL 113341 A IL113341 A IL 113341A
Authority
IL
Israel
Prior art keywords
chitosan
preparation
pharmaceutical compositions
compounds together
aqueous intranasal
Prior art date
Application number
IL11334195A
Other languages
English (en)
Other versions
IL113341A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL113341A0 publication Critical patent/IL113341A0/xx
Publication of IL113341A publication Critical patent/IL113341A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11334195A 1994-04-13 1995-04-12 Pharmaceutical compositions comprising aqueous intranasal antimigraine compounds together with chitosan and their preparation IL113341A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13

Publications (2)

Publication Number Publication Date
IL113341A0 IL113341A0 (en) 1995-07-31
IL113341A true IL113341A (en) 2000-08-31

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11334195A IL113341A (en) 1994-04-13 1995-04-12 Pharmaceutical compositions comprising aqueous intranasal antimigraine compounds together with chitosan and their preparation

Country Status (23)

Country Link
EP (1) EP0755253B1 (no)
JP (1) JP2921988B2 (no)
KR (1) KR100219952B1 (no)
CN (1) CN1146151A (no)
AT (1) ATE194915T1 (no)
AU (1) AU684360B2 (no)
BG (1) BG62197B1 (no)
BR (1) BR9507369A (no)
CA (1) CA2184822C (no)
CZ (1) CZ286610B6 (no)
DE (1) DE69518149T2 (no)
FI (1) FI118295B (no)
HR (1) HRP950149A2 (no)
HU (1) HU219495B (no)
IL (1) IL113341A (no)
NO (1) NO310276B1 (no)
NZ (1) NZ284454A (no)
PL (1) PL179761B1 (no)
RO (1) RO115414B1 (no)
SI (1) SI9500121A (no)
SK (1) SK129896A3 (no)
WO (1) WO1995028158A1 (no)
ZA (1) ZA953038B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
ATE194915T1 (de) 2000-08-15
JP2921988B2 (ja) 1999-07-19
HU9602806D0 (en) 1996-11-28
WO1995028158A1 (en) 1995-10-26
AU2305495A (en) 1995-11-10
CA2184822C (en) 2000-12-19
RO115414B1 (ro) 2000-02-28
JPH09505606A (ja) 1997-06-03
CZ286610B6 (cs) 2000-05-17
NO310276B1 (no) 2001-06-18
SI9500121A (en) 1995-10-31
HU219495B (hu) 2001-04-28
SK129896A3 (en) 1997-05-07
EP0755253A1 (en) 1997-01-29
NO964333D0 (no) 1996-10-11
FI964095A (fi) 1996-10-11
KR100219952B1 (ko) 1999-09-01
HRP950149A2 (en) 1997-06-30
NO964333L (no) 1996-10-11
PL179761B1 (pl) 2000-10-31
DE69518149D1 (de) 2000-08-31
PL316756A1 (en) 1997-02-03
CN1146151A (zh) 1997-03-26
HUT75939A (en) 1997-05-28
FI118295B (fi) 2007-09-28
BR9507369A (pt) 1997-09-23
EP0755253B1 (en) 2000-07-26
ZA953038B (en) 1996-10-14
CZ292096A3 (en) 1997-02-12
IL113341A0 (en) 1995-07-31
AU684360B2 (en) 1997-12-11
BG100889A (en) 1997-07-31
BG62197B1 (bg) 1999-05-31
CA2184822A1 (en) 1995-10-26
FI964095A0 (fi) 1996-10-11
NZ284454A (en) 1997-12-19
DE69518149T2 (de) 2001-03-22

Similar Documents

Publication Publication Date Title
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
MY113733A (en) Salts of an anti-migraine indole derivative
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
MX9603314A (es) Composiciones que contienen nebivolol micronizado.
GB2363985B (en) Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
HUT71798A (en) Process for preparing pharmaceutical compositions of antidepressant activity containing 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol)
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
IL113341A (en) Pharmaceutical compositions comprising aqueous intranasal antimigraine compounds together with chitosan and their preparation
AU7266291A (en) A novel substituted-amine compound and a process for the preparation thereof
HK1053109A1 (en) Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions comprising the same, methods for preparing them and the use for the preparation of a medicament of them
HU913520D0 (en) Process for the production of 7-acyl-3(substituted carbamoiloxy)-cefem-derivatives and of the medical preparations containing them
WO2001007418A3 (en) Ceramide analogs, process for their preparation and their use as antitumor agents
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
MX9604690A (es) Composicion antimigraña intranasal.
MY129110A (en) Polysaccharide compound having immune stimulating activity
YU41003A (sh) Polisaharidno jedinjenje koje poseduje imuno stimulativno dejstvo

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees